Valassi, E., Aulinas, A., Glad, C. A., Johannsson, G., Ragnarsson, O., & Webb, S. M. (2017). A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome. Clinical Endocrinology, 87(5), 433. https://doi.org/10.1111/cen.13414
Chicago Style (17th ed.) CitationValassi, Elena, Anna Aulinas, Camilla AM Glad, Gudmundur Johannsson, Oskar Ragnarsson, and Susan M. Webb. "A Polymorphism in the CYP17A1 Gene Influences the Therapeutic Response to Steroidogenesis Inhibitors in Cushing's Syndrome." Clinical Endocrinology 87, no. 5 (2017): 433. https://doi.org/10.1111/cen.13414.
MLA (9th ed.) CitationValassi, Elena, et al. "A Polymorphism in the CYP17A1 Gene Influences the Therapeutic Response to Steroidogenesis Inhibitors in Cushing's Syndrome." Clinical Endocrinology, vol. 87, no. 5, 2017, p. 433, https://doi.org/10.1111/cen.13414.